Madrigal shares skyrocket on positive NASH treatment study results By: Philadelphia Business Journal via Business Journals December 19, 2022 at 09:36 AM EST The Conshohocken company expects to seek approval for its treatment of an inflammatory liver disease during the first half of 2023. Read More >>
